DK2252575T3 - 2-amino-2-phenylalkanolderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse - Google Patents

2-amino-2-phenylalkanolderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse

Info

Publication number
DK2252575T3
DK2252575T3 DK09720924.1T DK09720924T DK2252575T3 DK 2252575 T3 DK2252575 T3 DK 2252575T3 DK 09720924 T DK09720924 T DK 09720924T DK 2252575 T3 DK2252575 T3 DK 2252575T3
Authority
DK
Denmark
Prior art keywords
amino
preparation
pharmaceutical compositions
compositions containing
phenylalkanol
Prior art date
Application number
DK09720924.1T
Other languages
English (en)
Inventor
Alexis Denis
Jean Pachot
Christophe Dini
Original Assignee
Oroxcell
Alexis Denis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oroxcell, Alexis Denis filed Critical Oroxcell
Application granted granted Critical
Publication of DK2252575T3 publication Critical patent/DK2252575T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/48Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02Monothiocarbamic acids; Derivatives thereof
    • C07C333/04Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms
    • C07D317/40Vinylene carbonate; Substituted vinylene carbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK09720924.1T 2008-01-31 2009-01-30 2-amino-2-phenylalkanolderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse DK2252575T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0800521A FR2927076B1 (fr) 2008-01-31 2008-01-31 Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent
US8482908P 2008-07-30 2008-07-30
PCT/FR2009/000106 WO2009112703A1 (fr) 2008-01-31 2009-01-30 Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK2252575T3 true DK2252575T3 (da) 2013-02-18

Family

ID=39273809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09720924.1T DK2252575T3 (da) 2008-01-31 2009-01-30 2-amino-2-phenylalkanolderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse

Country Status (25)

Country Link
US (1) US8217075B2 (da)
EP (1) EP2252575B1 (da)
JP (1) JP5497665B2 (da)
KR (1) KR20110103834A (da)
CN (1) CN101932552B (da)
AU (1) AU2009224558B2 (da)
BR (1) BRPI0907097A2 (da)
CA (1) CA2712489A1 (da)
DK (1) DK2252575T3 (da)
ES (1) ES2400080T3 (da)
FR (1) FR2927076B1 (da)
GE (1) GEP20125563B (da)
HK (1) HK1147090A1 (da)
IL (1) IL206936A (da)
MA (1) MA32125B1 (da)
MX (1) MX2010008430A (da)
MY (1) MY152406A (da)
NZ (1) NZ587677A (da)
PL (1) PL2252575T3 (da)
PT (1) PT2252575E (da)
RU (1) RU2486174C2 (da)
TW (1) TWI393561B (da)
UA (1) UA101013C2 (da)
WO (1) WO2009112703A1 (da)
ZA (1) ZA201005316B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948660B1 (fr) * 2009-07-30 2011-08-19 Oroxcell Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent
CN102276487B (zh) * 2011-06-29 2013-06-12 岳阳亚王精细化工有限公司 一种曲美布汀的制备方法
WO2022225427A1 (ru) * 2021-04-22 2022-10-27 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые соли [2-(диметиламино)-2-фенилбутил]-3,4,5-триметоксибензоата и их применение

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1434826A (en) * 1973-11-14 1976-05-05 Gallardo Antonio Sa Esters and carbamates of aminoalkanols
FR2669333B1 (fr) 1990-11-16 1993-03-19 Univ Rouen Procede de separation des enantiomeres des 5-aryl-5-alkylhydantouines.
FR2765218B1 (fr) 1997-06-30 1999-08-13 Jouveinal Inst Rech Le (s) 3,4,5-trimethoxybenzoate de 2-methylamino-2-phenyl-n- butyle, son application au traitement des douleurs chroniques
EP1110549A1 (en) * 1999-12-23 2001-06-27 Warner-Lambert Company Use of trimebutine for treating pain
SV2001000242A (es) * 1999-12-23 2001-10-25 Warner Lambert Co Combinacion de trimebutina con un analgesico derivado del opio
TW200524868A (en) * 2003-07-31 2005-08-01 Zeria Pharm Co Ltd Benzylamine derivatives
CN101489986A (zh) * 2006-06-06 2009-07-22 安泰碧治疗公司 曲美布汀和n-去甲基曲美布汀的盐

Also Published As

Publication number Publication date
AU2009224558B2 (en) 2013-05-02
ZA201005316B (en) 2011-10-26
MX2010008430A (es) 2010-12-07
AU2009224558A1 (en) 2009-09-17
CN101932552A (zh) 2010-12-29
US20090197924A1 (en) 2009-08-06
RU2010136307A (ru) 2012-03-10
IL206936A (en) 2013-08-29
NZ587677A (en) 2012-06-29
US8217075B2 (en) 2012-07-10
JP5497665B2 (ja) 2014-05-21
CN101932552B (zh) 2014-06-18
PT2252575E (pt) 2013-03-05
JP2011510961A (ja) 2011-04-07
BRPI0907097A2 (pt) 2015-07-07
HK1147090A1 (da) 2011-07-29
CA2712489A1 (en) 2009-09-17
WO2009112703A1 (fr) 2009-09-17
MY152406A (en) 2014-09-30
KR20110103834A (ko) 2011-09-21
RU2486174C2 (ru) 2013-06-27
MA32125B1 (fr) 2011-03-01
EP2252575B1 (fr) 2012-12-19
IL206936A0 (en) 2010-12-30
WO2009112703A8 (fr) 2009-12-03
FR2927076A1 (fr) 2009-08-07
FR2927076B1 (fr) 2010-03-26
GEP20125563B (en) 2012-06-25
UA101013C2 (ru) 2013-02-25
ES2400080T3 (es) 2013-04-05
TWI393561B (zh) 2013-04-21
PL2252575T3 (pl) 2013-05-31
EP2252575A1 (fr) 2010-11-24
TW200942230A (en) 2009-10-16

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
DK2107055T3 (da) Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK3421471T3 (da) Purin- og deazapurinderivater som farmaceutiske forbindelser
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
DK2069336T3 (da) Pyridin-4-yl-derivater som immunomodulerende midler
DK2231614T3 (da) Quinolinderivativer og anvendelse af disse som fungicider
BRPI0721651A2 (pt) Composição farmacêutica
IL214175A (en) Derivatives of aminotetralin, their pharmaceutical compositions and their use
RU2493831C3 (ru) Фармацевтические композиции
BRPI0919331A2 (pt) derivados de pirazolo piridina, composições farmacêuticas e métodos associados
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
DK2242740T3 (da) SF5-derivater som par1-inhibitorer, deres fremstilling og anvendelse som lægemidler
IL195813A0 (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
DK2350026T3 (da) Sulfoximinsubstituerede anilinopyrimidinderativer som cdk-inhibitorer, fremstilling og anvendelse heraf som lægemiddel
DK2281822T3 (da) Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
DK2038294T3 (da) 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-oner) og farmaceutiske præparater, der indeholder disse
DK2252609T3 (da) Pyridin-2-yl-derivater som immunomodulerende midler